Australia has one of the world’s best cancer survival rates, but treatment outcomes vary widely among different cancer types. While increasing numbers of breast, bowel, prostate and skin cancer patients are living longer lives after diagnosis, by comparison there has been little progress in the survival of brain, pancreatic, head and neck, bladder, lung and other complex and rare cancers. Read more
Relatively good progress in survival seems to correlate to the level of community awareness. Cancer survivors make effective ambassadors for a cause. For example, breast and prostate cancer survivors have done a great job to help get those cancers on the public agenda.
A new deal has been announced today after CSL has signed a deal with a Johnson & Johnson subsidiary to develop a new treatment for an aggressive form of leukemia. It is known as CSL362 and the treatment is part way through a phase one safety study in acute myeloid leukemia (AML) for patients who have achieved remission but face a high risk of relapse. Read more
This time of Leukemia is known to have poor survival rates, in particular for those aged over 50.